Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FJ4EH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,850
Award facts
- Contract value 100% obligated
- $43,850.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43,850.35 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose injections. This contract, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed price transaction with no set-aside designation. The award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of brand-name and generic medications to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record with the DLA demonstrates consistent capability to meet federal procurement requirements through competitive awards and firm fixed pricing arrangements across a wide spectrum of pharmaceutical products. This specific order for Cosentyx, a specialty immunosuppressant medication, reflects the company's role in ensuring pharmaceutical supply chain support for military medical operations and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FJ4EH?
SPE2DB25FJ4EH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FJ4EH worth?
The government has obligated $43,850 on SPE2DB25FJ4EH.
Is contract SPE2DB25FJ4EH an order under another contract?
Yes. SPE2DB25FJ4EH is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4EH competed?
The extent of competition for SPE2DB25FJ4EH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award